PD-L1 expression has also been linked to the mesenchymal GBM subtype and sarcomatous dedifferentiation, suggesting that it contributes to both immune evasion and tumor-intrinsic aggressiveness through EMT-related pathways [44]. The gene discussed is CD274; the disease is neoplasm.